Abstract
Advancements in artificial intelligence (AI) are revolutionising the healthcare sector, but challenges exist in AI adoption and its long-term use. This umbrella review aimed to identify the facilitators and barriers of AI implementation within hospitals and was registered on PROSPERO. Five databases (MEDLINE, HMIC, CINAHL Plus, Web of Science and Cochrane Reviews) were searched in January 2025, 763 articles were screened, with 13 included. The inclusion criteria encompassed studies implementing AI that were conducted within the hospital setting. The quality of the data were assessed using the ROBIS checklist and data were extracted using the NASSS (Nonadoption, Abandonment, and challenges to the Scale-up, Spread, and Sustainability) framework, to demonstrate how AI implementation was affected by: whether the AI solution had been technologically validated to ensure generalisability across departments; evidence the AI solution brings measurable gains; a lack of trust or understanding among hospital staff; the budgets and resources available to onboard the AI solution, train staff, and maintain the solution; the need for national policies on funding and regulating AI solutions. These factors affected the adoption, spread, scalability and sustainability of AI implementation and could be considered in future implementation efforts. The study was funded by the NIHR (NIHR205439).
Competing Interest Statement
The study was funded by the NIHR (NIHR205439).
Funding Statement
The study was funded by the NIHR (NIHR205439).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
